INTERNATIONAL PATENT: GASHERBRUM BIO, INC., HUANG, WEI FILES APPLICATION FOR "HETEROARYL-HETEROCYCLOALKYL-BASED GLP-1 AGONISTS"

GENEVA, March 8 -- GASHERBRUM BIO, INC. (601 Gateway Blvd. Suite 900, South San FranciscoCalifornia 94080), HUANG, Wei (5 F, JLABS@Shanghai, No. 1 South Bldg., Jin Chuang, 4560 JinKe Rd, Zhangjiang Hi-Tech ParkPudong New Area, Shanghai 200003) filed a patent application (PCT/CN2024/115894) for "HETEROARYL-HETEROCYCLOALKYL-BASED GLP-1 AGONISTS" on Aug 30, 2024. With publication no. WO/2025/045208, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LEI, Hui (5 F, JLABS@Shanghai, No. 1 South Bldg., Jin Chuang, 4560 JinKe Rd, Zh...